Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Solid Tumors
Interventions: DRUG: INC280
Sponsor: Novartis Pharmaceuticals